MEDIPHASE VENTURE PARTNERS
Mediphase Venture Partners is a venture capital firm focusing on health care and life sciences companies.
MEDIPHASE VENTURE PARTNERS
Industry:
Finance Financial Services Venture Capital
Status:
Active
Contact:
(617) 332-3408
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Maps PHP GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region
Similar Organizations
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
David C. Lubner
David C. Lubner Financial Consultant @ Mediphase Venture Partners Financial Consultant
Paul A. Howard
Paul A. Howard Founding Partner @ Mediphase Venture Partners Founding Partner 1999-06-01
Amanda Cobb
Amanda Cobb Operations Manager @ Mediphase Venture Partners Operations Manager
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2012-08-14 | Relypsa | Mediphase Venture Partners investment in Series C - Relypsa | 80 M USD |
2012-07-01 | Relypsa | Mediphase Venture Partners investment in Private Equity Round - Relypsa | 62.4 M USD |
2011-08-08 | Relypsa | Mediphase Venture Partners investment in Series B - Relypsa | 70.13 M USD |
2010-09-13 | Relypsa | Mediphase Venture Partners investment in Series B - Relypsa | 70 M USD |
2010-06-01 | Tetraphase Pharmaceuticals | Mediphase Venture Partners investment in Series C - Tetraphase Pharmaceuticals | 45 M USD |
2010-01-11 | ImpactRx | Mediphase Venture Partners investment in Series E - ImpactRx | 1.2 M USD |
2009-09-22 | Tetraphase Pharmaceuticals | Mediphase Venture Partners investment in Series B - Tetraphase Pharmaceuticals | 25 M USD |
2008-08-07 | Tetraphase Pharmaceuticals | Mediphase Venture Partners investment in Series A - Tetraphase Pharmaceuticals | 15 M USD |
2008-08-05 | Wellpartner | Mediphase Venture Partners investment in Series D - Wellpartner | 16.1 M USD |
2008-04-30 | Concert Pharmaceuticals | Mediphase Venture Partners investment in Series C - Concert Pharmaceuticals | 37 M USD |